Cargando…
Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, w...
Autores principales: | Bhargava, Ajay, Pelech, Steven, Woodard, Ben, Kerwin, John, Maherali, Nimet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769155/ https://www.ncbi.nlm.nih.gov/pubmed/26882073 http://dx.doi.org/10.7554/eLife.09976 |
Ejemplares similares
-
Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
por: Repass, John, et al.
Publicado: (2016) -
Registered report: The CD47-signal regulated protein alpha (SIRPa)
interaction is a therapeutic target for human solid tumors
por: Chroscinski, Denise, et al.
Publicado: (2015) -
RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF
por: Poulikakos, Poulikos I., et al.
Publicado: (2010) -
RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017) -
Registered report: Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF
por: Bhargava, Ajay, et al.
Publicado: (2016)